Spyre Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 Sep 24 | Sell€472,895 | Scott Burrows | Individual | 18,531 | €25.52 |
Insider Trading Volume
Insider Buying: 3920 insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,999,744 | 3.8% |
VC/PE Firms | 5,716,466 | 10.9% |
Hedge Funds | 7,276,461 | 13.8% |
Institutions | 37,582,093 | 71.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1158%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,507,983 | €192.1m | 14% | 0.01% | |||
4,018,101 | €102.8m | 962% | 8.22% | |||
3,258,360 | €83.4m | 45.9% | 1.39% | |||
3,031,018 | €77.6m | 18.6% | 1.89% | |||
2,685,448 | €68.7m | 23.7% | 3.1% | |||
2,514,538 | €64.3m | 388% | 3.33% | |||
2,403,441 | €61.5m | 332% | no data | |||
1,988,084 | €50.9m | 5.52% | 3.51% | |||
1,911,566 | €48.9m | 284% | no data | |||
1,839,138 | €47.1m | 0% | 0.68% | |||
1,756,667 | €44.9m | 44.8% | 1.34% | |||
1,409,659 | €36.1m | 949% | no data | |||
1,152,411 | €29.5m | 4.27% | 0.06% | |||
880,804 | €22.5m | 267% | 0.01% | |||
795,946 | €20.4m | -2.08% | no data | |||
765,834 | €19.6m | 132% | no data | |||
746,907 | €19.1m | 0% | no data | |||
741,904 | €19.0m | 0% | 0.01% | |||
707,586 | €18.1m | 0% | 0.02% | |||
696,480 | €17.8m | 179% | 0.99% | |||
687,080 | €17.6m | 0% | 0.12% | |||
673,867 | €17.2m | 4,720% | 0.01% | |||
666,000 | €17.0m | 42.9% | 0.12% | |||
575,000 | €14.7m | 130% | 1.81% | |||
513,420 | €13.1m | 25.2% | 2.39% |